Estrogen Pill or Patch?What Studies Show About Blood Clot Risk
Menopause & HormonesArticleHormone therapy pills have been linked to a higher risk of blood clots in the legs and lungs. Large studies found that estrogen through the skin, as a patch or gel, wasn't linked to that extra risk. Here is what the research shows and what to ask when choosing a form.

In this article
Blood clots in the leg veins or lungs, called venous thromboembolism (VTE), are one of the best-known risks of menopause hormone therapy. Research suggests the risk depends a lot on how estrogen enters your body.
Pills: a higher clot risk
A 2008 review of 17 studies found that estrogen pills raised the risk of a first clot, with about 2.5 times the odds of women not using estrogen.1 The risk was highest in the first year and dropped back to normal after women stopped.1 Being overweight or having an inherited clotting tendency raised the risk further for women taking pills.1
A large 2019 U.K. study of more than 80,000 women with clots and nearly 400,000 without found:2
- Estrogen pills overall were linked to about 1.6 times the odds of a clot.
- The odds were higher with estrogen plus a progestogen (1.7) than estrogen alone (1.4).
- Estradiol pills carried less risk than conjugated equine estrogens.
- Conjugated equine estrogen with medroxyprogesterone had the highest risk, about twice the odds.
Patches and gels: no clear added risk
In both studies, estrogen through the skin, called transdermal estrogen, wasn’t linked to a higher clot risk.12 The 2008 review found it didn’t seem to add risk even for women at higher risk of clots.1
Clinicians writing in a 2024 prescribing journal said transdermal estrogen is preferred for women at risk of clots, and that the route of estrogen and the type of progestogen both matter.3 The 2019 authors noted that patches and gels seemed to be underused.2
Keep it in perspective
These are observational studies, which show links rather than proof.2 Researchers say more data are needed on the many different regimens.1 Your overall risk depends on your age, weight, history and other medicines.
Questions to ask
- Do I have risk factors for clots, such as a past clot, family history, obesity or smoking?
- Would a patch, gel or spray suit me better than a pill?
- Which progestogen would I take, and does it matter for my risk?
- What symptoms of a clot should make me call right away?
Our guides to whether hormone therapy is safe, estrogen gel precautions, a loose estrogen patch and sequential versus continuous combined therapy explain more.
Try: “My mother had a blood clot. If I start hormone therapy, should it be a patch or gel instead of a pill?”
My Body Changed. Now What? includes a Visit Brief. Use it to list your clot risk factors, family history and current medicines before you choose a form. See the book.
This article is for general educational purposes only and is not medical advice. It isn't a substitute for diagnosis or treatment from a qualified healthcare professional who knows your health history. Please don't stop or switch a prescribed hormone therapy without talking to your prescriber. Seek emergency care for leg swelling or pain in one leg, sudden shortness of breath, chest pain, or coughing up blood. If you think you may be having a medical emergency, call 911 or your local emergency number right away. This article discusses published research on classes of medicines. Girl Playbook does not endorse any specific product, test, or provider.
Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.
Sources
The research behind this article, in the order it’s cited. How we source our articles.
- BMJ (full text via PubMed Central), 2008Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis (opens in a new tab)abcdef
- BMJ (full text via PubMed Central), 2019Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases (opens in a new tab)abcd
- Australian Prescriber (full text via PubMed Central), 2024Evidence-based management of menopause (letters) (opens in a new tab)↩
Spotted something out of date? Tell us and we’ll check it.


